IMPACT CLL & MCL: IMPlementing Advances in Cancer Treatment for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Click Here to Participate in CME/CE Activity

To participate in the CE/CME activity, please click the participation button above.

Patient Education: Click here to access education for your CLL patients on how to work with their healthcare team.

Target Audience

This educational activity is intended for an audience of hematologists/oncologists, members of the oncology multidisciplinary team (MDT; nurses, nurse practitioners, pharmacists, physician assistants), and other clinicians who care for patients with CLL or MCL globally, excluding the United Kingdom. 

Description

The goal of this activity is for learners to be better able to implement a coordinated, multidisciplinary approach in managing patients with CLL and MCL, integrate current treatment strategies, and manage adverse events effectively to improve patient outcomes.

Learning Objectives

Upon completion of this activity, participants will:

• Create treatment plans for patients with B-cell malignancies based on recommendations of the MDT
• Select strategies for the management of treatment-related side effects
• Plan collaboratively with the MDT to optimize the care of patients with B-cell malignancies

Continuing Education Credits Available

Physicians
Maximum of 1.00 AMA PRA Category 1 Credit(s)™

ABIM Diplomates
Maximum of 1.00 ABIM MOC points

Nurses
1.00 ANCC Contact Hour(s) (0.75 contact hours are in the area of pharmacology)

Pharmacists
1.00 Knowledge-based ACPE (0.100 CEUs)

Providers

This activity is developed through a collaboration between The Leukemia & Lymphoma Society and Medscape Oncology.

Supporters

This activity is supported by an independent educational grant from Lilly. 

For questions, concerns, or assistance for people with disabilities or grievances, please contact LLS at: [email protected].